Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent-Reference-Cited by-同舟云学术

Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent

Published:2022-08 Issue:8 Volume:8 Page:e10023
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Mammadov Orkhan,Akkurt Burak Han,Musigmann Manfred,Ari Asena Petek,Blömer David A.,Kasap Dilek N.G.,Henssen Dylan J.H.A.^ORCID,Nacul Nabila Gala,Sartoretti Elisabeth,Sartoretti Thomas^ORCID,Backhaus Philipp^ORCID,Thomas Christian,Stummer Walter,Heindel Walter^ORCID,Mannil Manoj^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference34 articles.

1. Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma;Ronellenfitsch;Acta Neuropathol. Commun.,2018

2. Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine–DNA Methyltransferase Biomarker Analyses

3. Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma;Duerinck;J. Neuro Oncol.,2018

4. Longitudinal MRI findings in patients with newly diagnosed glioblastoma after intraoperative radiotherapy;Forster;J. Neuroradiol.,2020

5. PPX and concurrent radiation for newly diagnosed glioblastoma without MGMT methylation: a randomized phase II study: BrUOG 244;Elinzano;Am. J. Clin. Oncol.,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative imaging predictors of tumor progression and pseudoprogression: A systematic review;Critical Reviews in Oncology/Hematology;2024-10

2. The Promise of Artificial Intelligence in Neuroanesthesia: An Update;Journal of Neuroanaesthesiology and Critical Care;2024-08-06

3. CFINet: Cross-Modality MRI Feature Interaction Network for Pseudoprogression Prediction of Glioblastoma;Journal of Computational Biology;2024-07-08

4. Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?;Radiology;2024-02-01

5. Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma;Cancers;2023-05-05